Insider · CIK 0001598129

Fratamico Arthur

Reports to the SEC for 4 companies · BURLINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001598129

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-27	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2021-05-25	Panbela Therapeutics, Inc.A Award	Director	AAward	+4,316 sh	—	—	9,615
2021-05-25	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,368
2021-01-26	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+75K sh	—	—	75,000
2020-12-01	Panbela Therapeutics, Inc.A Award	Director	AAward	+2,875 sh	—	—	5,299
2020-09-01	Panbela Therapeutics, Inc.P Purchase	Director	PPurchase	+2,424 sh	—	—	2,424
2020-09-01	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	Director	PPurchase	+2,424 sh	—	—	2,424
2020-06-24	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-01-31	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+74.4K sh	—	—	74,435
2019-12-19	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2019-12-19	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+26.8K sh	—	—	26,800
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−152K sh	$15.71	−$2.39M	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−13.8K sh	$6.60	−$90.8K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−13.8K sh	$12.72	−$175K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−19.3K sh	$12.42	−$239K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−14.5K sh	$12.22	−$177K	0
2016-10-24	Vitae Pharmaceuticals, IncU Disposition from Tender	Chief Business Officer	UDisposition from Tender	−13.2K sh	$21.00	−$278K	0
2016-08-15	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+14.5K sh	—	—	14,500
2016-04-29	Vitae Pharmaceuticals, IncA Award	Chief Business Officer	AAward	+2,086 sh	$6.11	+$12.7K	12,086
2016-02-15	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+19.3K sh	—	—	19,250
2015-08-27	Vitae Pharmaceuticals, IncP Purchase	Chief Business Officer	PPurchase	+10K sh	$7.83	+$78.3K	10,000
2015-08-14	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+13.8K sh	—	—	13,750
2015-02-13	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+13.8K sh	—	—	13,750

Recent filings

Accepted (ET)
Mar 294
Fratamico Arthur0001437749-23-008411
SEC(opens sec.gov)
May 274
Fratamico Arthur0001437749-21-013595
SEC(opens sec.gov)
Jan 284
Fratamico Arthur0000899243-21-003608
SEC(opens sec.gov)
Dec 34
Fratamico Arthur0001437749-20-024769
SEC(opens sec.gov)
Sep 14
Fratamico Arthur0001437749-20-019144
SEC(opens sec.gov)
Jun 264
Fratamico Arthur0001437749-20-014006
SEC(opens sec.gov)
Feb 44
Fratamico Arthur0000899243-20-002871
SEC(opens sec.gov)
Dec 234
Fratamico Arthur0001437749-19-024819
SEC(opens sec.gov)
Oct 254
Vitae Pharmaceuticals, Inc0001104659-16-151941
SEC(opens sec.gov)
Aug 174
Vitae Pharmaceuticals, Inc0001104659-16-140288
SEC(opens sec.gov)
Feb 164
Vitae Pharmaceuticals, Inc0001104659-16-097376
SEC(opens sec.gov)

Companies

Address

C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301

BURLINGTON, MA, 01803